Last reviewed · How we verify
NCT02658643
Analysis of Biliodigestive Anastomosis Techniques (BDA)
NA trial testing Continuous suture technique in Continuous or Interrupted Suture in 80 participants. Completed in 17 September 2019.
17 September 2019
Quick facts
| Lead sponsor | Technische Universität Dresden |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 20 January 2016 |
| Primary completion | 17 September 2019 |
| Estimated completion | 17 September 2019 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Continuous suture technique
- Interrupted suture technique
Conditions studied
- Continuous or Interrupted Suture — all drugs for Continuous or Interrupted Suture →
Sponsor
Technische Universität Dresden — full company profile →
Who can join
18 and older, any sex, with Continuous or Interrupted Suture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this prospective randomized controlled study is to determine the benefit-risk ratio (success rate, complication rate, tolerance) for patients with biliodigestive anastomosis by either continuous or interrupted suture.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Interrupted versus continuous suture technique for biliary-enteric anastomosis: randomized clinical trial.
Seifert L, von Renesse J, Seifert AM, Sturm D, et al · · 2023 · cited 13× · PMID 36723996 · DOI 10.1093/bjsopen/zrac163 -
The effectiveness of combined extrahepatic bile duct resection in radically resected cases with intrahepatic cholangiocarcinoma: a SEER-based retrospective cohort study and an external validation.
Lv TR, Wang JK, Li FY, Hu HJ. · · 2024 · PMID 38788199 · DOI 10.1097/js9.0000000000001661
Verify or expand the search:
- PubMed search for NCT02658643
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Technische Universität Dresden trials
Trials by the same sponsor.
- NCT07150598 — Immune-Marker Platform for Patients With Advanced Lung Cancer · not yet recruiting
- NCT06717958 — Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute M · Phase 2 · recruiting
- NCT06701487 — Role of Pavlovian Mechanisms for Control Over Substance Use · recruiting
- NCT03865277 — Individualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging · Phase 2 · not yet recruiting
- NCT06293170 — Automated Screening for Clinically Ascertained Loss of Cerebral Functions · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02658643 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Technische Universität Dresden
- Last refreshed: 22 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02658643.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing